Interleukin-10 and the pathogenesis of human visceral leishmaniasis.
The mechanisms underlying the failure to control the growth and systemic spread of Leishmania parasites in human visceral leishmaniasis (VL) are not well understood. Although the absence of antigen-specific Th1 responses in the peripheral blood mononuclear cells from VL patients is thought to be causally related to disease progression, the finding that these patients also express elevated interferon-gamma mRNA in lesional tissue, as well as elevated serum levels of proinflammatory cytokines, suggests that their immunological defect cannot be explained simply by immune tolerance or Th2 polarization. As a possible homeostatic mechanism to control persistent infection-induced inflammation, elevated levels of the regulatory cytokine interleukin (IL)-10 have been reported repeatedly in clinical studies of VL. Here, we review the studies with relevance to immune responses in human VL and highlight the central role that IL-10 might have in the pathogenesis of VL and as a target for immune-based therapy.
Nylén
Susanne
S
Laboratory of Parasitic Diseases, Bldg 4 RmB1-12, National Institute of Allergy and Infectious Diseases, 4 Center Drive MSC0425, Bethesda, MD 20892-0425, USA.
Sacks
David
D
D000818:Animals; D006801:Humans; D016753:Interleukin-10 / Q000502:physiology*; D007893:Leishmania donovani / Q000254:growth & development / Q000276:immunology; D018314:Leishmania infantum / Q000254:growth & development / Q000276:immunology; D007898:Leishmaniasis, Visceral / Q000209:etiology* / Q000276:immunology / Q000469:parasitology*
D016753:Interleukin-10